(Q44580834)

4 December 2017

title

Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients (English)

1 reference

stem cell transplantation

4 December 2017

main subject

1 reference

Shapira MY

1

1 reference

4 December 2017

Resnick IB

2

1 reference

4 December 2017

Bitan M

3

1 reference

4 December 2017

Ackerstein A

4

1 reference

4 December 2017

Samuel S

5

1 reference

4 December 2017

Elad S

6

1 reference

4 December 2017

Miron S

7

1 reference

4 December 2017

Zilberman I

8

1 reference

4 December 2017

Slavin S

9

1 reference

4 December 2017

Or R

10

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Bone Marrow Transplantation

4 December 2017

published in

1 reference

4 December 2017

volume

34

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

155-159

1 reference

Variable number of tandem repeat (VNTR) markers for human gene mapping

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

Immunotherapy of cancer with alloreactive lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

Clinical outcome of aortic valve replacement in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

7 January 2021

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

7 January 2021

Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

7 January 2021

Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

7 January 2021

High-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly versus younger lymphoma patients: a matched analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

7 January 2021

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704540

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704540

1 reference

4 December 2017

1 reference